A chemical probe toolbox for dissecting the cancer epigenome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Integrative approaches in Alzheimer's disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM).Frontiers in pharmacology · 2025
   Review
2. Getting a handle on chemical probes of chomatin readers.Future medicinal chemistry · 2021
   Article
3. Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.Cancer research · 2020
   Review
4. Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy.Frontiers in oncology · 2020
   Review
5. Epigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation.JACC. Basic to translational science · 2018
   Review
6. Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation.Molecules (Basel, Switzerland) · 2018
   Review
7. Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.Wiley interdisciplinary reviews. Systems biology and medicine · 2018
   Review
8. The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.Molecular cell · 2017
   Article
9. Unravelling biology and shifting paradigms in cancer with single-cell sequencing.Nature reviews. Cancer · 2017
   Review

Corrections and comments

• Erratum for
  A chemical probe toolbox for dissecting the cancer epigenome.2017

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.